PPMD For You:
Schedule a one-to-one meeting
for personalized support.powered by Calendly

March 29, 2017 /

Akashi Provides Update on HT-100 (March 2017)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Akashi Provides Update on HT-100 (March 2017)

Parent Project Muscular Dystrophy and Akashi Therapeutics hosted a webinar on March 27, 2017 to discuss HT-100 and next steps for the clinical program. Akashi CEO Marc Blaustein presented data from the previous clinical program of HT-100, discussed FDA’s recent decision to allow the clinical development of HT-100 to resume, and answered questions from the community.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List